Skip to content

Other Financing at other companies

OSI Systems logo
OSI SystemsOSIS
$486K+46.8%
Danaher logo
DanaherDHR
-$28M-233%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
-$600K+25.0%
IAR
Integra LifeSciencesIART
$0-100%
Novanta logo
NovantaNOVT
$4.39M
Teledyne Technologies logo
Teledyne TechnologiesTDY
-$10.3M-115%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-13.0%
P/E15.2×+0.3×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's other financing?
GE HealthCare Technologies (GEHC) reported other financing of -$2M in Q1 2026.
How has GE HealthCare Technologies's other financing changed year-over-year?
GE HealthCare Technologies's other financing increased by 66.7% year-over-year, from -$6M to -$2M.
What is the long-term trend for GE HealthCare Technologies's other financing?
Over 4 years (2021 to 2025), GE HealthCare Technologies's other financing has grown at a 58.0% compound annual growth rate (CAGR), from -$13M to -$81M.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.